State Street
TRVI icon

State Street’s Trevi Therapeutics TRVI Stock Holding History

State Street’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.8M Buy
2,665,313
+230,313
+9% +$2.58M ﹤0.01% 1979
2025
Q4 		$30.5M Buy
2,435,000
+215,578
+10% +$2.49M ﹤0.01% 2019
2025
Q3 		$20.3M Buy
2,219,422
+386,502
+21% +$2.9M ﹤0.01% 2234
2025
Q2 		$10M Buy
1,832,920
+408,414
+29% +$2.54M ﹤0.01% 2603
2025
Q1 		$8.96M Buy
1,424,506
+253,824
+22% +$1.21M ﹤0.01% 2595
2024
Q4 		$4.82M Buy
1,170,682
+217,770
+23% +$697K ﹤0.01% 2999
2024
Q3 		$3.18M Buy
952,912
+53,051
+6% +$158K ﹤0.01% 3157
2024
Q2 		$2.68M Buy
899,861
+101,612
+13% +$282K ﹤0.01% 3198
2024
Q1 		$2.75M Buy
798,249
+57,056
+8% +$127K ﹤0.01% 3171
2023
Q4 		$993K Buy
741,193
+32,600
+5% +$49.4K ﹤0.01% 3482
2023
Q3 		$1.54M Buy
708,593
+28,000
+4% +$63.3K ﹤0.01% 3422
2023
Q2 		$1.63M Buy
680,593
+581,051
+584% +$1.46M ﹤0.01% 3476
2023
Q1 		$184K Hold
99,542
– – ﹤0.01% 4104
2022
Q4 		$192K Buy
99,542
+22,500
+29% +$44.3K ﹤0.01% 4115
2022
Q3 		$119K Buy
77,042
+37,200
+93% +$122K ﹤0.01% 4394
2022
Q2 		$112K Buy
39,842
+3,000
+8% +$7.37K ﹤0.01% 4477
2022
Q1 		$81K Buy
+36,842
New +$38.2K ﹤0.01% 4700

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return